ARHGDIB and acute lymphoblastic leukemia: Results show that RhoGDI2 sh2 significantly reduces the cell number migrated to CXCL12, indicating that RhoGDI2 inhibits CXCR4-mediated T-ALL migration toward CXCL12 (Figures 2C,D).